傅玉 编委

学术贡献

• 1、学术研究成果：Jie Li, Wei Tang, Yi Yang, Qing Shen, Yang Yu, Xiaoyou Wang, Yu Fu* and Chong Li*. A Programmed Cell-Mimicking Nanoparticle Driven by Potato Alkaloid for Targeted Cancer Chemoimmunotherapy. Advanced Healthcare Materials 2021, 10, 2100311； Yu Fu, Leilei Wang, Wei Liu, Lan Yang, Lin Li, Luyao Wang, Xun Sun, Zhi-rong Zhang, Qing Lin*, Ling Zhang*. OX40L blockade cellular nanovesicles for autoimmune diseases therapy. Journal of Controlled Release 337 (2021) 557–570；Yu Fu, Qin Lin, Zhirong Zhang*. Association of TNFSF4 polymorphisms with systemic lupus erythematosus: a meta‑analysis. Advances in rheumatology (2021) 61:59；Yu Fu, Qin Lin, Zhirong Zhang*, Ling Zhang*, Therapeutic effect of the costimulatory molecule OX40 in T-cell mediated immunity, Acta Pharmaceutica Sinica B 2020;10:414-433 ；Yu Fu, Wei Liu, Luyao Wang, Biyue Zhu, Mengke Qu, Liuqing Yang, Xun Sun, Tao Gong, Zhirong Zhang, Qin Lin*, Ling Zhang*. Erythrocyte-Membrane-Camouflaged Nanoplatform for Intravenous Glucose-Responsive Insulin Delivery. Advanced Functional Materials, 28(2018)1802250 ；Yu Fu, Qing Lin, Tao Gong, Xun Sun, Zhi-rong Zhang*. Renal-targeting triptolide-glucosamine conjugate exhibits lower toxicity and superior efficacy in attenuation of ischemia/reperfusion renal injury in rats. Acta Pharmacologica Sinica (2016) 37:1467-1480；傅玉，林箐，张志荣*. 雷公藤甲素及其氨基葡萄糖结合物表观溶解度、油水分布系数和解离常数的测定. 华西药学杂志. 2017,32(4) ∶369-371